Exercise could slow withering effects of Alzheimer’s

Summary: For those with mild cognitive impairment (MCI) and other risk factors for Alzheimer’s disease, participating in aerobic exercise several times a week may slow neurodegeneration. Aerobic exercise reduced hippocampal atrophy in those with MCI.

Source: UT Southwestern Medical Center

Exercising several times a week may delay brain deterioration in people at high risk for Alzheimer’s disease, according to a study that scientists say merits further research to establish whether fitness can affect the progression of dementia.

Research from UT Southwestern found that people who had accumulation of amyloid beta in the brain – a hallmark of Alzheimer’s disease – experienced slower degeneration in a region of the brain crucial for memory if they exercised regularly for one year.

Although exercise did not prevent the eventual spread of toxic amyloid plaques blamed for killing neurons in the brains of dementia patients, the findings suggest an intriguing possibility that aerobic workouts can at least slow down the effects of the disease if intervention occurs in the early stages.

“What are you supposed to do if you have amyloid clumping together in the brain? Right now doctors can’t prescribe anything,” said Dr. Rong Zhang, who led the clinical trial that included 70 participants ages 55 and older. “If these findings can be replicated in a larger trial, then maybe one day doctors will be telling high-risk patients to start an exercise plan. In fact, there’s no harm in doing so now.”

Reduced brain atrophy

The study published in the Journal of Alzheimer’s Disease compared cognitive function and brain volume between two groups of sedentary older adults with memory issues: One group did aerobic exercise (at least a half-hour workout four to five times weekly), and another group did only flexibility training.

Both groups maintained similar cognitive abilities during the trial in areas such as memory and problem-solving. But brain imaging showed that people from the exercise group who had amyloid buildup experienced slightly less volume reduction in their hippocampus – a memory-related brain region that progressively deteriorates as dementia takes hold.

“It’s interesting that the brains of participants with amyloid responded more to the aerobic exercise than the others,” said Dr. Zhang, who conducted the trial at the Institute for Exercise and Environmental Medicine.

“Although the interventions didn’t stop the hippocampus from getting smaller, even slowing down the rate of atrophy through exercise could be an exciting revelation.”

However, Dr. Zhang notes that more research is needed to determine how or if the reduced atrophy rate benefits cognition.

Elusive answers

The search for dementia therapies is becoming increasingly pressing: More than 5 million Americans have Alzheimer’s disease, and the number is expected to triple by 2050.

Recent research has helped scientists gain a greater understanding of the molecular genesis of the disease, including a UT Southwestern discovery published last year that is guiding efforts to detect the condition before symptoms arise. Yet the billions of dollars spent on trying to prevent or slow dementia have yielded no proven treatments that would make an early diagnosis actionable for patients.

Fitness and brain health

Dr. Zhang is among a group of scientists across the world trying to determine if exercise may be the first such therapy.

His latest research builds upon numerous studies suggesting links between fitness and brain health. For example, a 2018 study showed that people with lower fitness levels experienced faster deterioration of vital nerve fibers in the brain called white matter. Research in mice has similarly shown exercise correlated with slower deterioration of the hippocampus – findings that prompted Dr. Zhang to investigate whether the same effects could be found in people.

“I’m excited about the results, but only to a certain degree,” Dr. Zhang said. “This is a proof-of-concept study, and we can’t yet draw definitive conclusions.”

Expanded research

Dr. Zhang is leading a five-year national clinical trial that aims to dig deeper into potential correlations between exercise and dementia.

This is an illustration of amyloid beta in neurons
In the Alzheimer’s affected brain, abnormal levels of the amyloid beta protein clump together to form plaques (seen in brown) that collect between neurons and disrupt cell function. A UT Southwestern study shows people with abnormal amyloid beta accumulation experienced slower brain degeneration if they exercised regularly for one year. The image is credited to National Institute on Aging, NIH.

The trial, which includes six medical centers across the country, involves more than 600 older adults (ages 60-85) at high risk of developing Alzheimer’s disease. The study will measure whether aerobic exercise and taking specific medications to reduce high blood pressure and cholesterol can help preserve brain volume and cognitive abilities.

“Understanding the molecular basis for Alzheimer’s disease is important,” Dr. Zhang said. “But the burning question in my field is, ‘Can we translate our growing knowledge of molecular biology into an effective treatment?’ We need to keep looking for answers.”

Funding: The Journal of Alzheimer’s Disease study was supported by the National Institutes of Health. It included collaborations with staff at the Institute for Exercise and Environmental Medicine (IEEM), a partnership between UT Southwestern and Texas Health Presbyterian Hospital Dallas. Dr. Zhang is Director of the Cerebrovascular Laboratory at the IEEM and is a Professor of Neurology & Neurotherapeutics and Internal Medicine at UT Southwestern’s Peter O’Donnell Jr. Brain Institute.

About this neuroscience research article

UT Southwestern Medical Center
Media Contacts:
James Beltran – UT Southwestern Medical Center
Image Source:
The image is credited to National Institute on Aging, NIH.

Original Research: Closed access
“Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial”. Rong Zhang et al.
Journal of Alzheimer’s Disease doi:10.3233/JAD-181175.


Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial

The current evidence is inconclusive to support the benefits of aerobic exercise training (AET) for preventing neurocognitive decline in patients with amnestic mild cognitive impairment (aMCI).

To examine the effect of a progressive, moderate-to-high intensity AET program on memory and executive function, brain volume, and cortical amyloid-β (Aβ) plaque deposition in aMCI patients.

This is a proof-of-concept trial that randomized 70 aMCI patients to 12 months of AET or stretching and toning (SAT, active control) interventions. Primary neuropsychological outcomes were assessed by using the California Verbal Learning Test-second edition (CVLT-II) and the Delis–Kaplan Executive Function System (D-KEFS). Secondary outcomes were the global and hippocampal brain volumes and the mean cortical and precuneus Aβ deposition.

Baseline cognitive scores were similar between the groups. Memory and executive function performance improved over time but did not differ between the AET and SAT groups. Brain volume decreased and precuneus Aβ plaque deposition increased over time but did not differ between the groups. Cardiorespiratory fitness was significantly improved in the AET compared with SAT group. In amyloid positive patients, AET was associated with reduced hippocampal atrophy when compared with the SAT group.

The AET and SAT groups both showed evidence of slightly improved neuropsychological scores in previously sedentary aMCI patients. However, these interventions did not prevent brain atrophy or increases in cortical Aβ deposition over 12 months. In amyloid positive patients, AET reduced hippocampal atrophy when compared with the SAT group.

Feel free to share this Alzheimer’s Disease News.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.